29 related articles for article (PubMed ID: 8396979)
1. The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans.
Yen TC; Lin HD; Lee CH; Chang SL; Yeh SH
Eur J Nucl Med; 1994 Sep; 21(9):980-3. PubMed ID: 7995293
[TBL] [Abstract][Full Text] [Related]
2. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
3. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
Kujat C; Neidl K; Müller-Leisse C
Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
[TBL] [Abstract][Full Text] [Related]
5. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
[TBL] [Abstract][Full Text] [Related]
6. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
[TBL] [Abstract][Full Text] [Related]
8. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
Skowsky WR; Wilf LH
South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
[TBL] [Abstract][Full Text] [Related]
9. Imaging modalities in the follow-up of non-iodine avid thyroid carcinoma.
Mallin WH; Elgazzar AH; Maxon HR
Am J Otolaryngol; 1994; 15(6):417-22. PubMed ID: 7872477
[TBL] [Abstract][Full Text] [Related]
10. 99Tcm(V) DMSA: what is its current role in the management of patients with head and neck cancer?
Watkinson J; Clarke S
Nucl Med Commun; 1991 Feb; 12(2):79-82. PubMed ID: 1848360
[No Abstract] [Full Text] [Related]
11. [Tubulointerstitial nephropathy--radionuclide imaging diagnosis].
Kawamura J; Okuno T
Nihon Rinsho; 1995 Aug; 53(8):1944-53. PubMed ID: 7563633
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
